Both the high incidence and mortality rate of ovarian cancer, particularly among the European female population, require robust and inexpensive liquid biopsy tests to timely diagnose this cancer, and many efforts are focused on the development of appropriate electrochemical aptasensors for the CA-125 detection. This evidence concerns the gene MUC16 and cancer.